US 11167004
Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 11167004 (Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K38/00